Urine mRNA can predict kidney transplant rejection

Levels of mRNA for perforin and granzyme B are high in urinary cells from patients with acute transplant rejection.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Prompt diagnosis of acute kidney transplant rejection can improve the outcome of transplantation but it is dependent on the invasive procedure of allograft biopsy. In 29 March New England Journal of Medicine, researchers from Weill Medical College of Cornell University, New York describe a non-invasive diagnostic test for rejection based on measurement of mRNA encoding cytotoxic proteins in urinary cells.

Li et al measured mRNA encoding the cytotoxic proteins perforin and granzyme B in 24 urine specimens from 22 renal-allograft recipients with a biopsy-confirmed episode of acute rejection and in 127 samples from 63 recipients without rejection. They found that levels of mRNA for perforin and granzyme B were significantly higher in the urinary cells from the patients with acute rejection (p<0.001) (N Engl J Med 2001, 344:947-954).

Perforin and granzyme B cooperate to induce the death of target transplant cells and are present in the cytoplasmic granules of cytotoxic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro&nbsp;

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development